Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
On June 20th we participated on the ESC Cardio-Oncology 2025 in Florence, organised by the ESC Council of Cardio-Oncology, an event that brings together European & non-European specialists from Cardiology, Oncology, Hematology, Radiotherapy and related disciplines. The conference covers a wide range of topics to improve the prevention, diagnosis, treatment and management of cancer therapy-related […]
